rs7210574

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_199242.3(UNC13D):c.3198A>G(p.Glu1066=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.366 in 1,579,720 control chromosomes in the GnomAD database, including 118,072 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 22524 hom., cov: 33)

Exomes 𝑓: 0.35 ( 95548 hom. )

Consequence

UNC13D
NM_199242.3 synonymous

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 0.0140

Variant links:

Genes affected

UNC13D (HGNC:23147): (unc-13 homolog D) This gene encodes a protein that is a member of the UNC13 family, containing similar domain structure as other family members but lacking an N-terminal phorbol ester-binding C1 domain present in other Munc13 proteins. The protein appears to play a role in vesicle maturation during exocytosis and is involved in regulation of cytolytic granules secretion. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 3, a genetically heterogeneous, rare autosomal recessive disorder. [provided by RefSeq, Jul 2008]

UNC13D links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.6).

BP6

Variant 17-75828040-T-C is Benign according to our data. Variant chr17-75828040-T-C is described in ClinVar as [Benign]. Clinvar id is 263240.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-75828040-T-C is described in Lovd as [Benign].

BP7

Synonymous conserved (PhyloP=0.014 with no splicing effect.

BA1

GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.862 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
UNC13D	NM_199242.3 linkuse as main transcript	c.3198A>G	p.Glu1066=	synonymous_variant	32/32	ENST00000207549.9

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
UNC13D	ENST00000207549.9 linkuse as main transcript	c.3198A>G	p.Glu1066=	synonymous_variant	32/32	1	NM_199242.3	P1	Q70J99-1

Frequencies

GnomAD3 genomes

AF:

0.487

AC:

74087

AN:

152058

Hom.:

22457

Cov.:

show subpopulations

Gnomad AFR

AF:

0.869

Gnomad AMI

AF:

0.271

Gnomad AMR

AF:

0.338

Gnomad ASJ

AF:

0.499

Gnomad EAS

AF:

0.441

Gnomad SAS

AF:

0.361

Gnomad FIN

AF:

0.276

Gnomad MID

AF:

0.475

Gnomad NFE

AF:

0.337

Gnomad OTH

AF:

0.456

GnomAD3 exomes

AF:

0.385

AC:

73388

AN:

190804

Hom.:

15804

AF XY:

0.381

AC XY:

39316

AN XY:

103194

show subpopulations

Gnomad AFR exome

AF:

0.888

Gnomad AMR exome

AF:

0.303

Gnomad ASJ exome

AF:

0.497

Gnomad EAS exome

AF:

0.436

Gnomad SAS exome

AF:

0.383

Gnomad FIN exome

AF:

0.276

Gnomad NFE exome

AF:

0.343

Gnomad OTH exome

AF:

0.385

GnomAD4 exome

AF:

0.353

AC:

503670

AN:

1427544

Hom.:

95548

Cov.:

AF XY:

0.353

AC XY:

249594

AN XY:

707378

show subpopulations

Gnomad4 AFR exome

AF:

0.897

Gnomad4 AMR exome

AF:

0.304

Gnomad4 ASJ exome

AF:

0.494

Gnomad4 EAS exome

AF:

0.461

Gnomad4 SAS exome

AF:

0.379

Gnomad4 FIN exome

AF:

0.276

Gnomad4 NFE exome

AF:

0.330

Gnomad4 OTH exome

AF:

0.396

GnomAD4 genome

AF:

0.488

AC:

74205

AN:

152176

Hom.:

22524

Cov.:

AF XY:

0.479

AC XY:

35629

AN XY:

74382

show subpopulations

Gnomad4 AFR

AF:

0.869

Gnomad4 AMR

AF:

0.338

Gnomad4 ASJ

AF:

0.499

Gnomad4 EAS

AF:

0.441

Gnomad4 SAS

AF:

0.361

Gnomad4 FIN

AF:

0.276

Gnomad4 NFE

AF:

0.337

Gnomad4 OTH

AF:

0.460

Alfa

AF:

0.381

Hom.:

8218

Bravo

AF:

0.515

Asia WGS

AF:

0.432

AC:

1500

AN:

3478

ClinVar

Significance: Benign

Submissions summary: Benign:10Other:1

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not specified

Benign:5

Benign, criteria provided, single submitter	clinical testing	Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	Mar 29, 2016	Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Benign, criteria provided, single submitter	clinical testing	Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan	Nov 12, 2023	This variant is classified as Benign based on local population frequency. This variant was detected in 39% of patients studied by a panel of primary immunodeficiencies. Number of patients: 37. Only high quality variants are reported. -
Benign, criteria provided, single submitter	clinical testing	PreventionGenetics, part of Exact Sciences	-	- -
Benign, no assertion criteria provided	clinical testing	Genome Diagnostics Laboratory, University Medical Center Utrecht	-	- -
Benign, no assertion criteria provided	clinical testing	Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center	-	- -

Familial hemophagocytic lymphohistiocytosis 3

Benign:4

Benign, criteria provided, single submitter	clinical testing	Genome-Nilou Lab	Dec 05, 2021	- -
Benign, criteria provided, single submitter	clinical testing	Illumina Laboratory Services, Illumina	Jan 12, 2018	This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitter	clinical testing	Invitae	Feb 01, 2024	- -
Benign, no assertion criteria provided	clinical testing	Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen	-	- -

not provided

Benign:1Other:1

not provided, no classification provided	phenotyping only	GenomeConnect, ClinGen	-	Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -
Benign, criteria provided, single submitter	clinical testing	GeneDx	Nov 12, 2018	- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.60

Cadd

Benign

9.6

Dann

Benign

0.82

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over